C. Michael Gibson, M.D.
C. Michael Gibson, M.D.
Harvard Medical School
Verified email at - Homepage
Cited by
Cited by
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 133 (4), e38-e360, 2016
Prasugrel versus clopidogrel in patients with acute coronary syndromes
SD Wiviott, E Braunwald, CH McCabe, G Montalescot, W Ruzyllo, ...
New England Journal of Medicine 357 (20), 2001-2015, 2007
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium
R Mehran, SV Rao, DL Bhatt, CM Gibson, A Caixeta, J Eikelboom, S Kaul, ...
Circulation 123 (23), 2736-2747, 2011
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ...
Journal of the American college of cardiology 75 (23), 2950-2973, 2020
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
MS Sabatine, CP Cannon, CM Gibson, JL López-Sendón, G Montalescot, ...
New England Journal of Medicine 352 (12), 1179-1189, 2005
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban
CP Cannon, WS Weintraub, LA Demopoulos, R Vicari, MJ Frey, N Lakkis, ...
New England Journal of Medicine 344 (25), 1879-1887, 2001
TIMI frame count: a quantitative method of assessing coronary artery flow
CM Gibson, CP Cannon, WL Daley, JT Dodge Jr, B Alexander, SJ Marble, ...
Circulation 93 (5), 879-888, 1996
Rivaroxaban in patients with a recent acute coronary syndrome
JL Mega, E Braunwald, SD Wiviott, JP Bassand, DL Bhatt, C Bode, ...
New England Journal of Medicine 366 (1), 9-19, 2012
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction
CP Cannon, CM Gibson, CT Lambrew, DA Shoultz, D Levy, WJ French, ...
Jama 283 (22), 2941-2947, 2000
Prevention of bleeding in patients with atrial fibrillation undergoing PCI
CM Gibson, R Mehran, C Bode, J Halperin, FW Verheugt, P Wildgoose, ...
New England Journal of Medicine 375 (25), 2423-2434, 2016
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised …
G Montalescot, SD Wiviott, E Braunwald, SA Murphy, CM Gibson, ...
The Lancet 373 (9665), 723-731, 2009
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis
TD Henry, BH Annex, GR McKendall, MA Azrin, JJ Lopez, FJ Giordano, ...
Circulation 107 (10), 1359-1365, 2003
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs
CM Gibson, CP Cannon, SA Murphy, KA Ryan, R Mesley, SJ Marble, ...
Circulation 101 (2), 125-130, 2000
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide
MS Sabatine, DA Morrow, JA de Lemos, CM Gibson, SA Murphy, N Rifai, ...
Circulation 105 (15), 1760-1763, 2002
Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI) 14 trial
EM Antman, RP Giugliano, CM Gibson, CH McCabe, P Coussement, ...
Circulation 99 (21), 2720-2732, 1999
Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study
MS Sabatine, CP Cannon, CM Gibson, JL López-Sendón, G Montalescot, ...
Jama 294 (10), 1224-1232, 2005
Andexanet alfa for acute major bleeding associated with factor Xa inhibitors
SJ Connolly, TJ Milling Jr, JW Eikelboom, CM Gibson, JT Curnutte, A Gold, ...
New England Journal of Medicine 375 (12), 1131-1141, 2016
Effect of platelet inhibition with cangrelor during PCI on ischemic events
DL Bhatt, GW Stone, KW Mahaffey, CM Gibson, PG Steg, CW Hamm, ...
New England Journal of Medicine 368 (14), 1303-1313, 2013
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
JL Mega, E Braunwald, S Mohanavelu, P Burton, R Poulter, F Misselwitz, ...
The Lancet 374 (9683), 29-38, 2009
The system can't perform the operation now. Try again later.
Articles 1–20